- Q1 2024 Dynavax Technologies Corp Earnings Call TranscriptMay 08, 2024$11.65 (-0.94%)Earnings
- Q4 2023 Dynavax Technologies Corp Earnings Call TranscriptFeb 22, 2024$12.44 (-0.16%)Earnings
- Dynavax Technologies Corp at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- Q3 2023 Dynavax Technologies Corp Earnings Call TranscriptNov 02, 2023$14.07 (-0.21%)Earnings
- Dynavax Technologies Corp at H.C. Wainwright & Co LLC 4th Annual Hepatitis B Virus (HBV) Conference (Virtual) TranscriptOct 25, 2023
- Q2 2023 Dynavax Technologies Corp Earnings Call TranscriptAug 03, 2023$13.39 (-1.11%)Earnings
- Dynavax Technologies Corp at Goldman Sachs Healthcare Conference TranscriptJun 12, 2023
- Dynavax Technologies Corp at William Blair Growth Stock Conference TranscriptJun 06, 2023
- Dynavax Technologies Corp at JMP Securities Life Sciences Conference TranscriptMay 15, 2023
- Q1 2023 Dynavax Technologies Corp Earnings Call TranscriptMay 02, 2023$10.31 (-2.00%)Earnings
- Q4 2022 Dynavax Technologies Corp Earnings Call TranscriptFeb 23, 2023$10.77 (-1.19%)Earnings
- Q3 2022 Dynavax Technologies Corp Earnings Call TranscriptNov 03, 2022$11.17 (-0.89%)Earnings
- Q2 2022 Dynavax Technologies Corp Earnings Call TranscriptAug 04, 2022$14.34 (+1.49%)Earnings
- Q1 2022 Dynavax Technologies Corp Earnings Call TranscriptMay 05, 2022$8.76 (-6.21%)Earnings
- Q4 2021 Dynavax Technologies Corp Earnings Call TranscriptFeb 28, 2022$12.26 (-1.76%)Earnings
- Q3 2021 Dynavax Technologies Corp Earnings Call TranscriptNov 04, 2021$20.76 (-0.86%)Earnings
- Dynavax Technologies Corp at Guggenheim Vaccine and Infectious Disease Conference (Virtual) TranscriptOct 05, 2021
- Dynavax Technologies Corp at Cantor Fitzgerald Global Healthcare Conference (Virtual) TranscriptSep 30, 2021
- Q2 2021 Dynavax Technologies Corp Earnings Call TranscriptAug 04, 2021$9.88 (+1.44%)Earnings
- Dynavax Technologies Corp at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2021
- Dynavax Technologies Corp Annual Shareholders Meeting TranscriptMay 28, 2021
- Q1 2021 Dynavax Technologies Corp Earnings Call TranscriptMay 06, 2021$8.88 (-0.67%)Earnings
- Dynavax Technologies Corp at Cowen Healthcare Conference (Virtual) TranscriptMar 01, 2021
- Q4 2020 Dynavax Technologies Corp Earnings Call TranscriptFeb 25, 2021$8.16 (-13.01%)Earnings
- Q3 2020 Dynavax Technologies Corp Earnings Call TranscriptNov 05, 2020$4.13Earnings
- Q2 2020 Dynavax Technologies Corp Earnings Call TranscriptAug 06, 2020$8.82 (-1.89%)Earnings
- Dynavax Technologies Corp Annual Shareholders Meeting TranscriptMay 28, 2020
- Q1 2020 Dynavax Technologies Corp Earnings Call TranscriptMay 07, 2020$4.54 (-2.58%)Earnings
- Dynavax Technologies Corp - To Discuss the Interim Analysis of Ongoing Clinical Trial Evaluating HEPLISAV-B - Conference Call TranscriptApr 30, 2020
- Q4 2019 Dynavax Technologies Corp Earnings Call TranscriptMar 11, 2020$3.07 (-18.13%)Earnings
- Q3 2019 Dynavax Technologies Corp Earnings Call TranscriptNov 06, 2019$5.23 (-2.43%)Earnings
- Q2 2019 Dynavax Technologies Corp Earnings Call TranscriptAug 07, 2019$2.99 (+3.82%)Earnings
- Q1 2019 Dynavax Technologies Corp Earnings Call TranscriptMay 08, 2019$6.53 (+0.31%)Earnings
- Q4 2018 Dynavax Technologies Corp Earnings Call TranscriptFeb 26, 2019$10.56 (+1.93%)Earnings
Dynavax Technologies Corp at William Blair Growth Stock Conference Transcript
Hi, everyone. My name is Matt Phipps. I'm a biotech analyst here at William Blair covering Dynavax. Thanks all for coming to our 43rd Annual Growth Stock Conference. Happy to have Ryan Spencer, the CEO of Dynavax, here. Bunch of us, the team is here as well for the breakout session.
But Ryan is going to walk us through kind of the story. And I do think it's an important time to look at the story, given what has been some really impressive growth of HEPLISAV recently and a bunch of pipeline readouts even today.
So with that, Ryan, go ahead and take over.
Thank you, Matt. Thanks for having us. Like Matt said, my name is Ryan Spencer, I have the pleasure of being the CEO of Dynavax.
Before we begin, I want to recognize that the presentation contains forward-looking statements that have certain risk and uncertainties that are highlighted in our risk factors in our Form 10-Q and 10-K, our SEC filings, which we encourage you to review.
So
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)